Disease Activity Progression in Systemic Lupus Erythematosus: An Analysis of the SLE Prospective Observational Cohort Study (SPOCS)

被引:0
|
作者
Morand, Eric [1 ]
Furie, Richard [2 ]
Peschken, Christine [3 ]
Aringer, Martin [4 ]
Arnaud, Laurent [5 ]
Desta, Barnabas [6 ]
Een, Tina Grunfeld [7 ]
Sorrentino, Alessandro [8 ]
Chen, Stephanie [9 ]
Ding, Bo [7 ]
机构
[1] Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic, Australia
[2] Northwell Hlth, Manhasset, NY USA
[3] Univ Manitoba, Winnipeg, MB, Canada
[4] Carl Gustav Carus, Dresden, Germany
[5] Univ Hosp Strasbourg, Strasbourg, France
[6] AstraZeneca, BioPharmaceut R&D, Gaithersburg, MD USA
[7] AstraZeneca, BioPharmaceut Med, Gothenburg, Sweden
[8] AstraZeneca, Med Affairs, Cambridge, England
[9] AstraZeneca, BioPharmaceut Med, Gaithersburg, MD USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2263
引用
收藏
页码:4484 / 4486
页数:3
相关论文
共 50 条
  • [41] Metabolomics in Systemic Lupus Erythematosus and Pregnancy - A Prospective Observational Longitudinal Study
    Luong, Shi-Nan
    Sheldon, Isabella
    Raine, Charles
    Jury, Elizabeth
    Giles, Ian
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 623 - 626
  • [42] An analysis of apoptosis in lymphoid organs and lupus disease in murine systemic lupus erythematosus (SLE)
    Ravirajan, CT
    Sarraf, CE
    Anilkumar, TV
    Golding, MCH
    Alison, MR
    Isenberg, DA
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 105 (02): : 306 - 312
  • [43] Disease activity, cumulative damage and quality of life in systemic lupus erythematosus (SLE).
    Hanly, JG
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 264 - 264
  • [44] Thyroid dysfunction in patients with systemic lupus erythematosus (SLE): relation to disease activity
    Mader, Reuven
    Mishail, Samer
    Adawi, Muhammed
    Lavi, Idit
    Luboshitzky, Rafael
    CLINICAL RHEUMATOLOGY, 2007, 26 (11) : 1891 - 1894
  • [45] IGG SUBCLASS LEVELS AND DISEASE-ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    MAYUS, J
    KAINE, J
    NAHM, M
    FEDERATION PROCEEDINGS, 1985, 44 (05) : 1716 - 1716
  • [46] Serum Albumin as a Marker for Disease Activity in Patients with Systemic Lupus Erythematosus (SLE)
    Yip, Jonathan
    Aghdassi, Ellie
    Su, Jiandong
    Lou, Wendy
    Reich, Heather
    Bargman, Joanne
    Scholey, James
    Gladman, Dafna
    Urowitz, Murray
    Fortin, Paul R.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1326 - 1326
  • [47] Thyroid dysfunction in patients with systemic lupus erythematosus (SLE): relation to disease activity
    Reuven Mader
    Samer Mishail
    Muhammed Adawi
    Idit Lavi
    Rafael Luboshitzky
    Clinical Rheumatology, 2007, 26 : 1891 - 1894
  • [48] DEPRESSION IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IN A DOMINICAN PATIENT COHORT
    Then, J.
    Loyo, E.
    Gotschalk, P.
    Vasquez, R.
    Franco, K.
    Tineo, C.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S53 - S53
  • [49] THE PROTEASOME INHIBITOR BORTEZOMIB AMELIORATES REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A PROSPECTIVE MULTI-CENTRE OBSERVATIONAL STUDY
    Alexander, T.
    Sarfert, R.
    Klotsche, J.
    Rubbert-Roth, A.
    Lorenz, H. -M.
    Rech, J.
    Hoyer, B.
    Cheng, Q.
    Waka, A.
    Taddeo, A.
    Kuehl, A. A.
    Schett, G.
    Burmester, G. -R.
    Radbruch, A.
    Hiepe, F.
    Voll, R. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 530 - 530
  • [50] Prevalence and Predictors of Peripheral Vascular Disease in a Cohort of Systemic Lupus Erythematosus (SLE) Patients
    Dey, Ida Dzifa
    Acquaye, Kelvin
    Yawson, Alfred
    Agyabeng, Kofi
    Yorke, Ernest
    Boima, Vincent
    Mate-Kole, Charles
    ARTHRITIS & RHEUMATOLOGY, 2018, 70